| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.098 | 0.001 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |